Therapeutic Role of Mobilized Bone Marrow Cells in Children with Nonischemic Dilated Cardiomyopathy

Table 2

Comparison between New York Heart Association class of group 1 patients before and after GCSF treatment.

	New York Heart Association classification before treatment
After treatment	I	II	III-IV	𝑃 value
	Number = 2 (10%)	Number = 12 (60%)	Number = 6 (30%)
I	2 (100)	11 (91.7)	2 (33.3)
II	0	1 (8.3)	2 (33.3)	0.002
III-IV	0	0	2 (33.3)